Lichen Planus Flashcards

1
Q

LICHEN PLANUS

What is lichen planus ?

A
  • Chronic cell-mediated immunological inflammatory condition.
  • Caused by immune-mediated cytotoxic T-cells.
  • Causing epithelial damage directed against basilar keratinocytes.
  • Unknown aetiology.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LICHEN PLANUS

Describe some of the aetiological factors which might possibily be involved in lichen planus ?

A
  • Contact hypersensitivity reaction i.e. amalgam.
  • Medication related - beta-blockers, ACE inhibitors, gold, quinine.
  • Medical condition related - GvHD, SLE.
  • Physical and emotional stress.
  • Isomorphic response - i.e. to trauma.
  • Isotrophic response - i.e. to local skin disease (VZV).
  • Systemic infection i.e. Hep C causing modification of self-antigens on basal keratinocytes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LICHEN PLANUS PRESENTATION

Describe the histological presentation of lichen planus.

A
  • Parakeratosis.
  • Orthokeratosis of epidermis.
  • Chronic T-cell inflammatory infiltrate in basement membrane from CT.
  • Patchy acanthosis.
  • Saw tooth rete pegs.
  • Civatte bodies.
  • Basal cell damage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LICHEN PLANUS PRESENTATION

Describe the signs/symptoms of lichen planus.

A
  • Pain (exacerbated by SLS, citrus, spicy).
  • Burning mouth sensation.
  • White/red patches in the mouth.
  • Desquamative gingivitis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LICHEN PLANUS PRESENTATION

Describe desquamtive gingivitis.

A
  • Full thickness erythema of the attached and unattached mucosa.
  • Not caused by presence of plaque, but can be exacerbated by it.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LICHEN PLANUS PRESENTATION

Name some subtypes of lichen planus.

A
  • Minor and major erosive/atrophic.
  • Reticular.
  • Ulcerative.
  • Plaque-like.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LICHEN PLANUS PRESENTATION

What mucosal surfaces of the mouth does lichen planus most commonly affect ?

A
  • Buccal mucosa.
  • Lateral border of the tongue.
  • Gingiva.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LICHEN PLANUS INVESTIGATIONS

What initial investigtaions would you wish to carry out where you suspect your patient has lichen planus ?

A

Incisional biopsy.
Blood tests - haematinics, FBC, autoantibody screen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LICHEN PLANUS MANAGEMENT

Where you suspect your patient has drug-related lichenoid reaction - how would you manage this ?

A

Discuss with GP - risk:benefit analysis of stopping/changing their medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LICHEN PLANUS MANAGEMENT

Where you suspect your patient has contact sensitivity lichen planus to an amalgam restoration - how would you manage this ?

A

Replace restoration with composite.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LICHEN PLANUS MANAGEMENT

Your patient has mild/intermittent lichen planus - how would you manage this patient is primary care ?

A

Chlorhexidine MW 0.2% - 10ml 2x daily for 2 mins.
Benzdiamine MW 0.15% - 15ml 2x daily for 2 mins.
Reassurance.
Suggest patient avoids trigger foods.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LICHEN PLANUS MANAGEMENT

You prescribe your patient chlorhexidine gluconate MW 0.2% - what is the properties and mechanism of action of this MW ?

A
  • Analgesic, anti-inflammatory, bacteriostatic, bacteriocidal.
  • Widespread antimicrobial.
  • Binds to negatively charged phosphate ions on bacteria surface membrane.
  • Alters the integrity of the cell membrane and causes apoptosis.
  • Binds to hard and soft tissues in the mouth for slow release.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LICHEN PLANUS MANAGEMENT

You prescribe your patient benzdamine MW 0.15% - what is the properties and mechanism of action of this MW ?

A
  • NSAID.
  • Inhibits the synthesis of IL1 and TNF-a.
  • Which prevents synthesis and chemotaxis of further pro-inflammatory markers (IL6 and IL8).
  • Results in anti-inflammatory and analgesic effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LICHEN PLANUS MANAGEMENT

Your patient presents with major/persistent lichen planus - how do you manage this patient in primary care setting ?

A
  • CHx gluconate MW 0.2% 20ml for 2 mins 2x daily.
  • Benzdamine MW 0.15% 15ml for 2mins 2x daily.
  • Avoid trigger foods and SLS-free toothpaste.

Prescribe either -
* Beclomethasome MDI 0.5mg 2x puffs 2-3x daily.
* Betamethasone MW 1mg tablet in 10-20ml of water for 2mins daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LICHEN PLANUS MANAGEMENT

Your patient with persistent/major lichen planus presents at their 2 week review following your primary care management and their condition has NOT improved - how do you then manage this patient ?

A

Referral to secondary care - OM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LICHEN PLANUS MANAGEMENT

You work in secondary care setting - referral from a GDP is made and the patient presents with persistent/major lichen planus which has been unresponsive to primary care treatment - what are your options for managing this patient ?

A
  • Short-term systemic steroids - prednisolone.
  • Topical higher strength steroids - tacrolimus or clobetasol (gingival veneer).
  • Immune-modulator medication - hydroxychloroquine, mycophenolate or azathioprine.
17
Q

LICHEN PLANUS MANAGEMENT

Describe the mechanism of action of mycophenolate.

A
  • Depletes guanosine nucleotides in T and B cells.
  • Therefore, inhibits T and B cell proliferation.
  • Which suppresses cell-mediated immune response.
18
Q

LICHEN PLANUS MANAGEMENT

Describe the mechanism of action of azathioprine.

A
  • DMARD medication.
  • Purine metabolism antagonist.
  • Inhibits DNA, RNA and protein synthesis of pro-inflammatory cells.
19
Q

LICHEN PLANUS MANAGEMENT

Describe the mechanism of action of beclomethasone & betamethasone.

A
  • Adrenocorticosteroid.
  • Decreases capillary permeability.
  • Decreases leukocyte and fibroblast migration.
  • Controls rate of protein synthesis.
  • Therefore, has anti-inflammatory effect.